From Esaote S.p.A.; Esaote introduced the new G-SCAN at the RSNA in Dec. 2004. The G-SCAN covers almost all musculoskeletal applications including the spine. The tilting gantry is designed for scanning in weight-bearing positions. This unique MRI scanner is developed in line with the Esaote philosophy of creating high quality MRI systems that are easy to install and that have a low breakeven point.

Short name: Gd-BOPTA, generic name: Gadobenate dimeglumine
A paramagnetic MRI contrast agent (small molecular weight Gd-chelate) with 0.5 and 0.25 molar concentration.
The albumin-mediated relaxation enhancement may result in advantages for Gd-BOPTA over Gd-DTPA and other gadolinium agents in poorly vascularized, small, or lesions with low enhancement and in tumors with high concentrations of albumin. The substance is excreted partly by the kidneys (75-90%), partly by the biliary system (10-25%). The uptake in the liver is about 5% in humans. It is bolus injectable.

See Contrast Agents and MultiHance®.

Short name: Gd-DO3A-butriol, generic name: Gadobutrol
A paramagnetic contrast agent with 0.5 and 1.0 molar concentration.

See Contrast Agents and Gadovist®.

Short name: Gd-DTPA-BMA, generic name: Gadodiamide, chemical compound: Gd-diethylenetriaminepentaacetate-bis(methylamide), central moiety: Gd
A paramagnetic MRI contrast agent (nonionic) with a small molecular weight linear chelate. Due to the linkage of two DTPA molecules through amide bonds the molecule is uncharged and has a low osmolality. The substance is excreted almost exclusively by the kidneys.

See also Nonionic Intravenous Contrast Agents and Omniscan®.

Short name: Gadofluorine-8 (M), central moiety: Gd2+
Gadofluorine is a substance appropriate for a lymph node specific MRI contrast agent (Bayer Schering Pharma AG) and a blood pool agent with positive enhancement.

See also Blood Pool Agents.